Industries - Drug Delivery Technologies Market Analysis by Route of Administration (Oral, Injectable, Topical, Ocular, Pulmonary, Nasal, Transmucosal, Implantable), by Application (Cancer, Autoimmune, Infectious, Cardiovascular, Respiratory, Diabetes), by End User, and by Region – Forecast to 2026

Ablation Technology Market Analysis

Drug Delivery Technologies Market Analysis by Route of Administration (Oral, Injectable, Topical, Ocular, Pulmonary, Nasal, Transmucosal, Implantable), by Application (Cancer, Autoimmune, Infectious, Cardiovascular, Respiratory, Diabetes), by End User, and by Region – Forecast to 2026
May 2021

SKU: N/A Category:
Clear
  • Description
  • Additional information
  • Enquire about

Description

Drug Delivery Technologies Market Analysis by Route of Administration (Oral, Injectable, Topical, Ocular, Pulmonary, Nasal, Transmucosal, Implantable), by Application (Cancer, Autoimmune, Infectious, Cardiovascular, Respiratory, Diabetes), by End User, and by Region - Forecast to 2026

Published: May 2021 | Historical Data: 2018-2020 | Base Year: 2020
SKU: ICI-HC-1130 | Number of Pages: 145 | Category: Pharmaceuticals

The global drug delivery technologies market size was valued at USD 4,937.0 million in 2020 and is expected to witness a CAGR of 7.8% during the forecast period. Rising R&D investment by biopharmaceutical and biotechnology companies for the development of novel drugs is a key driver for the growth of the global drug delivery technologies market. Additionally, the increase in prevalence of chronic diseases, cross-infection cases during the COVID-19 pandemic, technological advancements, government support, and growing demand for biologics for the treatment of chronic diseases are some of the other drivers propelling the market growth. However, concerns associated with injuries from needle stick and lack of knowledge for advanced drug delivery technology in developing nations are expected to restrain the global market growth.

Drug Delivery Technologies Market

By Route of Administration

Based on route of administration, the market is segmented into oral drug delivery, injectable drug delivery, topical drug delivery, ocular drug delivery, pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and implantable drug delivery. In 2020, the injectable drug delivery segment accounted for the significant revenue share and is expected to witness a lucrative CAGR during the forecast period. This is attributed to its wide adoption among medical practitioners for disease prevention. The topical drug delivery segment is projected to grow at the fastest CAGR during the forecast period. This is attributed to the associated benefits, such as ease and convenience of use, appropriate dosage, non-invasive and painless delivery, higher dispersion ability, and improved patient compliance.

By End User

Based on end user, the market is categorized into hospitals, ambulatory surgery centres/clinics, home care settings, diagnostic centres, and others. The hospitals segment accounted for the highest revenue share in 2020 and is projected to maintain its dominance over the forecast period. The rising chronic diseases, increasing prevalence of infectious diseases especially during the COVID-19 pandemic, and increasing surgical procedures is a key factor that drives the segment growth.

Regional Insights

In 2020, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of large patient pool, advanced medical services, and high investments in R&D in this region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the rising incidences of surgical procedures, chronic illness & viral diseases cases, escalating demand for advanced medication and treatment, and growing focus of CROs & biopharmaceutical companies in this region.

North America Drug Delivery Technologies Market Size (2018-2026), USD Million

North America Drug Delivery Technologies Market

Competitor Insights

Some of the key players in the drug delivery technologies market are Sanofi S.A. (France); Merck KGaA (Germany); Bristol Myers Squibb (U.S.); Teva Pharmaceutical Industries Ltd. (Israel); Genmab A/S (Denmark); AstraZeneca plc (U.K.); 3M Company (U.S.); GlaxoSmithKline plc (U.K.); Becton, Dickinson and Company (U.S.); Antares Pharma, Inc. (U.S.); Bayer AG (Germany); Pfizer Inc. (U.S.); F. Hoffmann-La Roche AG (Switzerland); Novartis International AG (Switzerland); and Johnson & Johnson (U.S.). The leading players operating in the drug delivery technologies industry are adopting various strategies including R&D investments, adoption of advanced techniques, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

Key Market Developments

  • May 2021: Researchers from Georgia Institute of Technology and Emory University developed a drug delivery technology using ultrasound and RNA-loaded nanoparticles that can overcome protective blood-brain barrier and deliver RNA-based drugs to treat brain tumors.
  • May 2021: Progenity (PROG), Inc. received funding from Crohn’s & Colitis Foundation IBD Ventures Fund for development of its  first-in-class oral Drug Delivery System (DDS) for the treatment of inflammatory bowel disease (IBD).

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2018 to 2026. The drug delivery technologies market report is categorized into the following segments and subsegments:

Drug Delivery Technologies Market, By Route of Administration (Revenue, USD Million, 2018 – 2026)

  • Oral Drug Delivery
    • Solid Oral Drugs
    • Liquid Oral Drugs
    • Semi-Solid Oral Drugs
  • Injectable Drug Delivery
    • Conventional Injection Devices
    • Self-Injection Devices
    • Other Injector Devices
  • Topical Drug Delivery
    • Liquid Formulations
    • Semi-Solid Formulations
    • Solid Formulations
    • Transdermal Products
  • Ocular Drug Delivery
    • Liquid Formulations
    • Semi-Solid Formulations
    • Ocular Devices
  • Pulmonary Drug Delivery
    • Metered-Dose Inhalers
    • Dry Powder Inhalers
    • Nebulizers
  • Nasal Drug Delivery
    • Nasal Drops
    • Nasal Sprays
    • Nasal Powders
    • Nasal Gels
  • Transmucosal Drug Delivery
    • Oral Formulations
    • Other Transmucosal Drug Delivery Technologies
  • Implantable Drug Delivery
    • Active Implantable Drug Delivery
    • Passive Implantable Drug Delivery

Drug Delivery Technologies Market, By End User (Revenue, USD Million, 2018 – 2026)

  • Hospitals
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Diagnostic Centers
  • Others

Digital Pathology Market, By Region (Revenue, USD Million, 2018 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Drug Delivery Technologies Market Report:

Key Parameters Details
Data Availability 2018-2026
Historical Years 2018-2020
Base Year Considered 2020
Forecast Period 2020-2026
Company Profiles 15
Companies Considered >50
Value Units Value in USD and CAGR in %
Market Segments Product and End User
Regional Coverage North America (U.S. and Canada), Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), and the Middle East & Africa (South Africa, Saudi Arabia, Rest of MEA)
Key Market Players Sanofi S.A. (France); Merck KGaA (Germany); Bristol Myers Squibb (U.S.); Teva Pharmaceutical Industries Ltd. (Israel); Genmab A/S (Denmark); AstraZeneca plc (U.K.); 3M Company (U.S.); GlaxoSmithKline plc (U.K.); Becton, Dickinson and Company (U.S.); Antares Pharma, Inc. (U.S.); Bayer AG (Germany); Pfizer Inc. (U.S.); F. Hoffmann-La Roche AG (Switzerland); Novartis International AG (Switzerland); and Johnson & Johnson (U.S.)
Custom Analysis Customization up to 60 analyst hours

Drug Delivery Technologies Market, By Route of Administration (Revenue, USD Million, 2018 – 2026)

  • Oral Drug Delivery
    • Solid Oral Drugs
    • Liquid Oral Drugs
    • Semi-Solid Oral Drugs
  • Injectable Drug Delivery
    • Conventional Injection Devices
    • Self-Injection Devices
    • Other Injector Devices
  • Topical Drug Delivery
    • Liquid Formulations
    • Semi-Solid Formulations
    • Solid Formulations
    • Transdermal Products
  • Ocular Drug Delivery
    • Liquid Formulations
    • Semi-Solid Formulations
    • Ocular Devices
  • Pulmonary Drug Delivery
    • Metered-Dose Inhalers
    • Dry Powder Inhalers
    • Nebulizers
  • Nasal Drug Delivery
    • Nasal Drops
    • Nasal Sprays
    • Nasal Powders
    • Nasal Gels
  • Transmucosal Drug Delivery
    • Oral Formulations
    • Other Transmucosal Drug Delivery Technologies
  • Implantable Drug Delivery
    • Active Implantable Drug Delivery
    • Passive Implantable Drug Delivery

Drug Delivery Technologies Market, By End User (Revenue, USD Million, 2018 – 2026)

  • Hospitals
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Diagnostic Centers
  • Others

Drug Delivery Technologies Market, By Region (Revenue, USD Million, 2018 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA
1. Research Methodology
  1.1. Research Objective
  1.2. Study Scope: Market Segments
  1.3. Study Timeframe, Limitations & Currency
  1.4. Domain-Assisted Cognition (DAC) Framework
    1.4.1. Three-stage Research Methodology
      1.4.1.1. Understand Ecosystem
        1.4.1.1.1. Secondary Research
        1.4.1.1.2. Primary Research
        1.4.1.1.3. Internal Repository
      1.4.1.2. Synthesize Information
        1.4.1.2.1. Data Analysis
        1.4.1.2.2. Data Triangulation
      1.4.1.3. Predict/Project Growth
        1.4.1.3.1. Market Size Estimation
          1.4.1.3.1.1. Bottom-up Approach
          1.4.1.3.1.2. Top-down Approach
        1.4.1.3.2. Data Validation
    1.4.2. Two-stage Quality Check Mechanism
      1.4.2.1. Inspection & Reporting
      1.4.2.2. Quality Audit
2. Market Summary
  2.1. Market Definition & Market Landscape
  2.2. Market Segment Snapshot
  2.3. Geographic Market Snapshot
3. Market Dynamics
  3.1. Market Driver Analysis
    3.1.1. Rising number of chronic illness patients
    3.1.2. Increasing sophisticated drug development process and delivery techniques
    3.1.3. Government initiatives for consumer awareness
    3.1.4. Growing stringency in product quality
    3.1.5. Technological advancement
  3.2. Market Restraint Analysis
    3.2.1. Concerns associated with injuries from needle stick
    3.2.2. Lack of knowledge for advanced drug delivery technology in developing nations
  3.3. Market Opportunities
    3.3.1. Increasing consumer awareness for home-based drug delivery and self-administration drug delivery
    3.3.2. Growing novel product development
    3.3.3. Mapping untapped market in emerging economies
4. Industry Outlook
  4.1. Key Market Trends
  4.2. Value Chain Analysis
  4.3. Porter’s 5 Forces Analysis
  4.4. Pricing Analysis (2018-2020)
  4.5. Product Benchmarking
5. Covid-19 Impact and Deviation Analysis
  5.1. Covid-19 Prevalence Analysis
  5.2. Key Market Trends
  5.3. Market Size Deviation Analysis (2020-2026)
6. Drug Delivery Technologies Market Size and Forecast, by Product (2018-2026), USD Million
  6.1. Oral Drug Delivery
    6.1.1. Solid Oral Drugs
    6.1.2. Liquid Oral Drugs
    6.1.3. Semi-Solid Oral Drugs
  6.2. Injectable Drug Delivery
    6.2.1. Conventional Injection Devices
    6.2.2. Self-Injection Devices
    6.2.3. Other Injector Devices
  6.3. Topical Drug Delivery
    6.3.1. Liquid Formulations
    6.3.2. Semi-Solid Formulations
    6.3.3. Solid Formulations
    6.3.4. Transdermal Products
  6.4. Ocular Drug Delivery
    6.4.1. Liquid Formulations
    6.4.2. Semi-Solid Formulations
    6.4.3. Ocular Devices
  6.5. Pulmonary Drug Delivery
    6.5.1. Metered-Dose Inhalers
    6.5.2. Dry Powder Inhalers
    6.5.3. Nebulizers
  6.6. Nasal Drug Delivery
    6.6.1. Nasal Drops
    6.6.2. Nasal Sprays
    6.6.3. Nasal Powders
    6.6.4. Nasal Gels
  6.7. Transmucosal Drug Delivery
    6.7.1. Oral Formulations
    6.7.2. Other Transmucosal Drug Delivery Technologies
  6.8. Implantable Drug Delivery
    6.8.1. Active Implantable Drug Delivery
    6.8.2. Passive Implantable Drug Delivery
7. Drug Delivery Technologies Market Size and Forecast, by End User (2018-2026), USD Million
  7.1. Hospitals
  7.2. Ambulatory Surgery Centers/Clinics
  7.3. Home Care Settings
  7.4. Diagnostic Centers
  7.5. Others
8. Drug Delivery Technologies Market, Regional Analysis (2018-2026), USD Million
  8.1. North America
    8.1.1. Introduction
      8.1.1.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.1.1.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
      8.1.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
    8.1.2. U.S.
      8.1.2.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.1.2.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.1.3. Canada
      8.1.3.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.1.3.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
  8.2. Europe
    8.2.1. Introduction
      8.2.1.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.2.1.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
      8.2.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
    8.2.2. Germany
      8.2.2.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.2.2.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.2.3. UK
      8.2.3.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.2.3.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.2.4. France
      8.2.4.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.2.4.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.2.5. Spain
      8.2.5.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.2.5.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.2.6. Italy
      8.2.6.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.2.6.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.2.7. Russia
      8.2.7.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.2.7.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.2.8. Rest of Europe
      8.2.8.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.2.8.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
  8.3. Asia Pacific (APAC)
    8.3.1. Introduction
      8.3.1.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.3.1.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
      8.3.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
    8.3.2. China
      8.3.2.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.3.2.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.3.3. Japan
      8.3.3.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.3.3.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.3.4. India
      8.3.4.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.3.4.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.3.5. Australia
      8.3.5.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.3.5.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.3.6. South Korea
      8.3.6.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.3.6.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.3.7. Rest of Asia Pacific
      8.3.7.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.3.7.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
  8.4. Latin America (LATAM)
    8.4.1. Introduction
      8.4.1.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.4.1.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
      8.4.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
    8.4.2. Brazil
      8.4.2.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.4.2.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.4.3. Mexico
      8.4.3.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.4.3.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.4.4. Argentina
      8.4.4.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.4.4.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.4.5. Rest of LATAM
      8.4.5.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.4.5.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
  8.5. Middle East & Africa (MEA)
    8.5.1. Introduction
      8.5.1.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.5.1.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
      8.5.1.3. Market Size & Forecast, by Country (2018-2026), USD Million
    8.5.2. South Africa
      8.5.2.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.5.2.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.5.3. Saudi Arabia
      8.5.3.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.5.3.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
    8.5.4. Rest of MEA
      8.5.4.1. Market Size & Forecast, by Route of Administration (2018-2026), USD Million
      8.5.4.2. Market Size & Forecast, by End-Use (2018-2026), USD Million
9. Competitor Analysis
  9.1. Market Player Comparison
  9.2. Product-wise Player Mapping
  9.3. Region-wise Player Mapping
  9.4. Market Share Analysis
  9.5. Market Position Analysis
  9.6. Recent Development Analysis
10. Company Profiles
  10.1. Sanofi S.A. (France)
    10.1.1. Company Overview
    10.1.2. Company Financials
    10.1.3. Product Portfolio
    10.1.4. Recent Developments
  10.2. Merck KGaA (Germany)
    10.2.1. Company Overview
    10.2.2. Company Financials
    10.2.3. Product Portfolio
    10.2.4. Recent Developments
  10.3. Bristol Myers Squibb (U.S.)
    10.3.1. Company Overview
    10.3.2. Company Financials
    10.3.3. Product Portfolio
    10.3.4. Recent Developments
  10.4. Teva Pharmaceutical Industries Ltd. (Israel)
    10.4.1. Company Overview
    10.4.2. Company Financials
    10.4.3. Product Portfolio
    10.4.4. Recent Developments
  10.5. Genmab A/S (Denmark)
    10.5.1. Company Overview
    10.5.2. Company Financials
    10.5.3. Product Portfolio
    10.5.4. Recent Developments
  10.6. AstraZeneca plc (U.K.)
    10.6.1. Company Overview
    10.6.2. Company Financials
    10.6.3. Product Portfolio
    10.6.4. Recent Developments
  10.7. 3M Company (U.S.)
    10.7.1. Company Overview
    10.7.2. Company Financials
    10.7.3. Product Portfolio
    10.7.4. Recent Developments
  10.8. GlaxoSmithKline plc (U.K.)
    10.8.1. Company Overview
    10.8.2. Company Financials
    10.8.3. Product Portfolio
    10.8.4. Recent Developments
  10.9. Becton, Dickinson and Company (U.S.)
    10.9.1. Company Overview
    10.9.2. Company Financials
    10.9.3. Product Portfolio
    10.9.4. Recent Developments
  10.10. Antares Pharma, Inc. (U.S.)
    10.10.1. Company Overview
    10.10.2. Company Financials
    10.10.3. Product Portfolio
    10.10.4. Recent Developments
  10.11. Bayer AG (Germany)
    10.11.1. Company Overview
    10.11.2. Company Financials
    10.11.3. Product Portfolio
    10.11.4. Recent Developments
  10.12. Pfizer Inc. (U.S.)
    10.12.1. Company Overview
    10.12.2. Company Financials
    10.12.3. Product Portfolio
    10.12.4. Recent Developments
  10.13. F. Hoffmann-La Roche AG (Switzerland)
    10.13.1. Company Overview
    10.13.2. Company Financials
    10.13.3. Product Portfolio
    10.13.4. Recent Developments
  10.14. Novartis International AG (Switzerland)
    10.14.1. Company Overview
    10.14.2. Company Financials
    10.14.3. Product Portfolio
    10.14.4. Recent Developments
  10.15. Johnson & Johnson (U.S.)
    10.15.1. Company Overview
    10.15.2. Company Financials
    10.15.3. Product Portfolio
    10.15.4. Recent Developments
(Note: Financials are captured for public listed companies)

Key questions addressed by the research report-

  1. What are the current market trends and future market forecast from 2020 to 2026 for drug delivery technologies market?
  2. What are the market dynamics and probable opportunities for market players during the forecast period?
  3. Initiatives undertaken by market players to address the COVID-19 impact to sustain in the competitive market
  4. Which geographies have immense opportunities in different segments of the drug delivery technologies market?
  5. What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?


    Have any question? Check your free sample before purchase or connect with our expert.

    Additional information

    Licensing Types

    , , ,

    Enquire about Drug Delivery Technologies Market Analysis by Route of Administration (Oral, Injectable, Topical, Ocular, Pulmonary, Nasal, Transmucosal, Implantable), by Application (Cancer, Autoimmune, Infectious, Cardiovascular, Respiratory, Diabetes), by End User, and by Region - Forecast to 2026